Bayer To Offer $1.1B To Buy California-Based Conceptus
German drugmaker Bayer has announced plans to acquire California-based Conceptus -- which manufactures Essure, a permanent birth control method -- for about $1.1 billion, or $31 per share. Finalization of the deal is subject to U.S. antitrust approval and expected by mid-2013.
- "Bayer To Pay $1.1B for California Firm Conceptus" (AP/Fresno Bee, 4/29).